Home›Companies›Biotech & Pharma›Regenerative Medical Solutions

Regenerative Medical Solutions, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 28, 2023·Suggest an edit

About Regenerative Medical Solutions

Regenerative Medical Solutions is a private company based in Madison, Wisconsin. It has reported $7,001,000 raised in five offerings on Form D since June 2013.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 25, 2023Aug 28, 2023$5,000,000target not set2$2.5MEquityRule 506(b)Form D ↗
Jul 31, 2018Aug 14, 2018$181,000of $3.0M target1$181KEquityRule 506(b)Form D ↗
Oct 29, 2014Nov 7, 2014$375,000of $3.0M target1$375KEquityRule 506(b)Form D ↗
Feb 3, 2014Feb 10, 2014amended Jul 18, 2014$595,000of $1.0M target9$66,111EquityRule 506(b)Form D/A ↗1 earlier filing
May 20, 2013Jun 20, 2013$850,000fully sold2$425KEquity06Form D ↗
Total, five offerings$7,001,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Regenerative Medical Solutions's Form D filed Aug 28, 2023.

AK
Anthony Kolton
President and Director

Earlier filings also listed Thomas Joyce (vice president, last listed Nov 2014), Guy Tagliavia (chief operating officer, last listed Nov 2014), Jon Odorico, MD, FACS (director, last listed Jul 2014) and Gary Gorman (director, last listed Jul 2014).

Sources

  1. SECRegenerative Medical Solutions, Inc. Form D, filed Feb 10, 2014
  2. SECRegenerative Medical Solutions, Inc. filing history